Nuclear Imaging Data‐Driven Classification of Parkinson's Disease
Authors:
Open Access
- 28 August 2023
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 38 (11) , 2053-2063
Abstract
BACKGROUND: Parkinson's disease (PD) is a heterogeneous neurodegenerative disorder characterized by motor and nonmotor symptoms. Several features have prognostic importance and have been used as key indicators for identifying clinical subtypes. However, the symptom‐based classification approach has limitations with respect to the stability of the obtained subtypes.OBJECTIVES: The purpose of this study was to identify subtypes of PD using nuclear imaging biomarkers targeting the cardiac sympathetic nervous and nigro‐striatal systems and to compare patterns of cortical morphological change among obtained subtypes.METHODS: We performed unbiased hierarchical cluster analysis using 123I‐metaiodobenzylguanidine cardiac scintigraphy and 123I‐N‐(3‐fluoropropyl)‐2β‐carbomethoxy‐3β‐(4‐iodophenyl) nortropane single photon emission computed tomography data for 56 patients with PD. We compared clinical characteristics and the patterns of cortical atrophy in the obtained clusters.RESULTS: Three clusters were identified and showed distinct characteristics in onset ages and dopamine‐replacement therapy and deep brain stimulation requirements. According to the characteristics, clusters were classified into two subtypes, namely, “cardio‐cortical impairment (CC)” and “dopaminergic‐dominant dysfunction (DD)” subtype. The three clusters were named according to subtype and time since onset in which 14 patients were classified as “early DD,” 25 as “advanced DD,” and 17 as “early CC.” Compared with the early DD subtype, the early CC subtype showed parietal‐dominant diffuse cortical atrophy and the advanced DD subtype showed left‐side predominant mild cortical atrophy.CONCLUSIONS: Nuclear imaging biomarker–based classification can be used to identify clinically and pathologically relevant PD subtypes with distinct disease trajectories. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.Keywords
This publication has 36 references indexed in Scilit:
- Deep-Brain Stimulation for Parkinson's DiseaseNew England Journal of Medicine, 2012
- Standardization of metaiodobenzylguanidine heart to mediastinum ratio using a calibration phantom: effects of correction on normal databases and a multicentre studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2011
- Semi-automated algorithm for calculating heart-to-mediastinum ratio in cardiac Iodine-123 MIBG imagingJournal of Nuclear Cardiology, 2011
- Cardiac sympathetic denervation and its association with cognitive deficits in Parkinson's diseaseParkinsonism & Related Disorders, 2009
- Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inferenceNeuroImage, 2009
- The progression of pathology in longitudinally followed patients with Parkinson’s diseaseActa Neuropathologica, 2008
- Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PDJournal of the Neurological Sciences, 2004
- Onset age and severity of motor impairment are associated with reduction of myocardial 123I-MIBG uptake in Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2003
- Staging of brain pathology related to sporadic Parkinson’s diseaseNeurobiology of Aging, 2003
- 4D deformation modeling of cortical disease progression in Alzheimer's dementiaMagnetic Resonance in Medicine, 2001